| Drug Type Interferons, Biosimilar | 
| Synonyms AP-001 | 
| Target | 
| Action agonists, stimulants, inducers | 
| Mechanism IFNAR agonists(Interferon alpha/beta receptor agonists), Immunostimulants, Innate antiviral immune response inducers | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePhase 2 | 
| First Approval Date- | 
| Regulation- | 

| KEGG | Wiki | ATC | Drug Bank | 
|---|---|---|---|
| - | Interferon alfa-2b (Helix BioPharma Corp.) | - | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Uterine Cervical Dysplasia | Phase 2 | - | - | |
| Warts | Phase 2 | - | - | 






